GNF-7 was originally identified as a Type II kinase inhibitor for BCR-ABL that delayed tumor growth in mouse model of chronic myelogenous leukemia [43,44]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.